Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04869696 · ClinicalTrials.gov registry record
Medical Adhesive Repeat Application Study
A clinical trial, sponsored by Solventum US.
- Completed
- Registry status
- 56
- Enrollment target
NCT04869696: Completed study, sponsored by Solventum US.
NCT04869696 is a clinical trial that has completed, run by Solventum US. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04869696 has completed, sponsored by Solventum US.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
Study Summary
This study is to determine the relative effects imparted by different medical tapes to skin when comparing normal skin to skin after ten repeated tape applications and removals.
Primary Outcome
Measure change in Transepidermal Water Loss (TEWL) from baseline to Tape 10 after repeated tape applications and removals. Baseline TEWL will be measured on another non-taped site.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2021-03-08 |
| Est. Completion | 2021-05-24 |
What the finished NCT04869696 record still lists
NCT04869696 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 56 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04869696 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04869696 about?
NCT04869696 is a clinical study titled "Medical Adhesive Repeat Application Study". This study is to determine the relative effects imparted by different medical tapes to skin when comparing normal skin to skin after ten repeated tape applications and removals.
What is the current status of trial NCT04869696?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2021-03-08. Estimated completion is 2021-05-24.
Who is sponsoring clinical trial NCT04869696?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI